Co-Authors
This is a "connection" page, showing publications co-authored by CHRIS AMOS and Vikram Shaw.
Connection Strength
3.196
-
An Atlas Characterizing the Shared Genetic Architecture of Inflammatory Bowel Disease with Clinical and Behavioral Traits. Inflamm Bowel Dis. 2024 Jun 03; 30(6):884-893.
Score: 0.955
-
A comprehensive analysis of lung cancer highlighting epidemiological factors and psychiatric comorbidities from the All of Us Research Program. Sci Rep. 2023 07 05; 13(1):10852.
Score: 0.896
-
Alternative polyadenylation shapes the molecular and clinical features of lung adenocarcinoma. Hum Mol Genet. 2025 Jan 23; 34(1):1-10.
Score: 0.250
-
Sex-Based Differences in Melanoma Survival Improvement from 2004 to 2018. Cancers (Basel). 2024 Mar 27; 16(7).
Score: 0.236
-
Racial and socioeconomic disparities in survival improvement of eight cancers. BJC Rep. 2024 Mar 11; 2(1):21.
Score: 0.235
-
Predicting Chemotherapy Benefit across Different Races in Early-Stage Breast Cancer Patients Using the Oncotype DX Score. Cancers (Basel). 2023 Jun 16; 15(12).
Score: 0.223
-
Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis. Nat Commun. 2023 02 24; 14(1):1069.
Score: 0.219
-
Meta-analyses uncover the genetic architecture of Idiopathic Inflammatory Myopathies. Arthritis Rheumatol. 2024 Dec 16.
Score: 0.062
-
The prognostic effect of infiltrating immune cells is shaped by proximal M2 macrophages in lung adenocarcinoma. Mol Cancer. 2024 Sep 04; 23(1):185.
Score: 0.061
-
Prognostic stratification in DLBCL patients with aberrant MYC gene. Br J Haematol. 2024 Nov; 205(5):1782-1793.
Score: 0.060